ARK Investment Management LLC and Catherine D. Wood filed a Schedule 13G with the SEC on November 13, 2026, reporting beneficial ownership of 10,043,508 shares of Prime Medicine, Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: ARK Investment Management LLC and Catherine D. Wood each reported beneficial ownership of 10,043,508 shares of Prime Medicine, Inc. common stock.
  • Percent of class: The 10,043,508 shares represent 5.54% of Prime Medicine's outstanding common stock, according to the filing.
  • Voting and dispositive power split: ARK holds sole voting power and sole dispositive power over all 10,043,508 shares; Catherine D. Wood holds shared voting power and shared dispositive power over the same 10,043,508 shares.
  • Triggering event date: The filing identifies September 30, 2026 as the date of the event requiring the statement.
  • Certifying signatories: Kathleen Fontano, Chief Compliance Officer of ARK, and Catherine D. Wood, Chief Executive Officer and Chief Investment Officer, signed the filing on November 13, 2026.

ARK and Catherine Wood Cross 5% Threshold in Prime Medicine Common Stock

According to the Schedule 13G filed November 13, 2026, ARK Investment Management LLC, a Delaware-organized investment adviser, and Catherine D. Wood, a United States citizen, jointly reported a position of 10,043,508 shares of common stock (CUSIP 74168J101) in Prime Medicine, Inc. (NASDAQ:PRME), whose principal executive offices are located at 60 First St., Cambridge, MA 02141. The filing was submitted pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, with the triggering event dated September 30, 2026.

The filing draws a clear distinction between how voting and dispositive authority is allocated between the two reporting persons. ARK holds sole voting power and sole dispositive power over all 10,043,508 shares, with zero shared power in either category. Catherine D. Wood, identified as holding no sole voting or dispositive power, is reported to hold shared voting power and shared dispositive power over the same 10,043,508 shares, reflecting her role as a control person of ARK.

The filing's certification states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Both ARK and Catherine D. Wood are listed at 200 Central Avenue, St. Petersburg, FL 33701. ARK is classified as an investment adviser (type "IA"), while Catherine D. Wood is classified as a holding company and individual (types "HC, IN").

What Was Disclosed

ARK Investment Management LLC and Catherine D. Wood disclosed aggregate beneficial ownership of 10,043,508 shares of Prime Medicine, Inc. common stock, equal to 5.54% of the class, as of September 30, 2026, via a Schedule 13G filed November 13, 2026.